| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8950847 | Clinical Colorectal Cancer | 2018 | 20 Pages |
Abstract
Previous bevacizumab use had no effect on the activity of subsequent EGFRIs. The apparent effect of time between biologic agents in right-sided tumors might reflect patient selection.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Matthew Burge, Christine Semira, Belinda Lee, Margaret Lee, Suzanne Kosmider, Rachel Wong, Jeremy Shapiro, Brigette Ma, Andrew P. Dean, Allan S. Zimet, Simone A. Steel, Sheau Wen Lok, Javier Torres, Melissa Eastgate, Hui-li Wong, Peter Gibbs,